{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:56:57Z","timestamp":1795107417734,"version":"4.10.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["Z01-Al-00988"],"award-info":[{"award-number":["Z01-Al-00988"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["Z01-Al-00644"],"award-info":[{"award-number":["Z01-Al-00644"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    X-linked Severe Combined Immunodeficiency (SCID-X1) due to\n                    <jats:italic>IL2RG<\/jats:italic>\n                    mutations is potentially fatal in infancy where \u2018emergency\u2019 life-saving stem cell transplant may only achieve incomplete immune reconstitution following transplant. Salvage therapy SCID-X1 patients over 2\u2009years old (NCT01306019) is a non-randomized, open-label, phase I\/II clinical trial for administration of lentiviral-transduced autologous hematopoietic stem cells following busulfan (6\u2009mg\/kg total) conditioning. The primary and secondary objectives assess efficacy in restoring immunity and safety by vector insertion site analysis (VISA). In this ongoing study (19 patients treated), we report VISA in blood lineages from first eight treated patients with longer follow up found a\u2009&gt;\u200960-fold increase in frequency of forward-orientated VIS within intron 3 of the High Mobility Group AT-hook 2 gene. All eight patients demonstrated emergence of dominant\n                    <jats:italic>HMGA2<\/jats:italic>\n                    VIS clones in progenitor and myeloid lineages, but without disturbance of hematopoiesis. Our molecular analysis demonstrated a cryptic splice site within the chicken \u03b2-globin hypersensitivity 4 insulator element in the vector generating truncated mRNA transcripts from many transcriptionally active gene containing forward-oriented intronic vector insert. A two base-pair change at the splice site within the lentiviral vector eliminated splicing activity while retaining vector functional capability. This highlights the importance of functional analysis of lentivectors for cryptic splicing for preclinical safety assessment and a redesign of clinical vectors to improve safety.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-31344-x","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T08:03:30Z","timestamp":1656403410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Lentivector cryptic splicing mediates increase in CD34+ clones expressing truncated HMGA2 in human X-linked severe combined immunodeficiency"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9800-774X","authenticated-orcid":false,"given":"Suk See","family":"De Ravin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9442-1134","authenticated-orcid":false,"given":"Colin L.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1706-2158","authenticated-orcid":false,"given":"Julie","family":"Brault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narda","family":"Whiting-Theobald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uimook","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Anaya","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Quackenbush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyra","family":"Estwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Karra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Docking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Kwatemaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghe","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5902-5868","authenticated-orcid":false,"given":"Sheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6623-6276","authenticated-orcid":false,"given":"Jennifer","family":"Puck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1088-8045","authenticated-orcid":false,"given":"Morton J.","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-0262","authenticated-orcid":false,"given":"Luigi D.","family":"Notarangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5874-5775","authenticated-orcid":false,"given":"Harry L.","family":"Malech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6432-1300","authenticated-orcid":false,"given":"Xiaolin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"key":"31344_CR1","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1056\/NEJMoa1815408","volume":"380","author":"E Mamcarz","year":"2019","unstructured":"Mamcarz, E. et al. Lentiviral gene therapy combined with low-dose busulfan in infants with SCID-X1. N. Engl. J. Med. 380, 1525\u20131534 (2019).","journal-title":"N. Engl. J. Med."},{"key":"31344_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41591-019-0735-5","volume":"26","author":"DB Kohn","year":"2020","unstructured":"Kohn, D. B. et al. Lentiviral gene therapy for X-linked chronic granulomatous disease. Nat. Med. 26, 200\u2013206 (2020).","journal-title":"Nat. Med."},{"key":"31344_CR3","doi-asserted-by":"publisher","first-page":"335ra357","DOI":"10.1126\/scitranslmed.aad8856","volume":"8","author":"SS De Ravin","year":"2016","unstructured":"De Ravin, S. S. et al. Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency. Sci. Transl. Med. 8, 335ra357 (2016).","journal-title":"Sci. Transl. Med."},{"key":"31344_CR4","doi-asserted-by":"publisher","first-page":"1233151","DOI":"10.1126\/science.1233151","volume":"341","author":"A Aiuti","year":"2013","unstructured":"Aiuti, A. et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott\u2013Aldrich syndrome. Science 341, 1233151 (2013).","journal-title":"Science"},{"key":"31344_CR5","doi-asserted-by":"publisher","first-page":"1233158","DOI":"10.1126\/science.1233158","volume":"341","author":"A Biffi","year":"2013","unstructured":"Biffi, A. et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 341, 1233158 (2013).","journal-title":"Science"},{"key":"31344_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature09328","volume":"467","author":"M Cavazzana-Calvo","year":"2010","unstructured":"Cavazzana-Calvo, M. et al. Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature 467, 318\u2013322 (2010).","journal-title":"Nature"},{"key":"31344_CR7","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.jaci.2014.06.021","volume":"134","author":"CC Dvorak","year":"2014","unstructured":"Dvorak, C. C. et al. Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency. J. Allergy Clin. Immunol. 134, 935\u2013943.e915 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"31344_CR8","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1093\/hmg\/2.8.1099","volume":"2","author":"JM Puck","year":"1993","unstructured":"Puck, J. M. et al. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum. Mol. Genet. 2, 1099\u20131104 (1993).","journal-title":"Hum. Mol. Genet."},{"key":"31344_CR9","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1126\/science.8266078","volume":"262","author":"SM Russell","year":"1993","unstructured":"Russell, S. M. et al. Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science 262, 1880\u20131883 (1993).","journal-title":"Science"},{"key":"31344_CR10","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.immuni.2019.03.028","volume":"50","author":"WJ Leonard","year":"2019","unstructured":"Leonard, W. J., Lin, J. X. & O\u2019Shea, J. J. The gammac family of cytokines: basic biology to therapeutic ramifications. Immunity 50, 832\u2013850 (2019).","journal-title":"Immunity"},{"key":"31344_CR11","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1126\/science.8266077","volume":"262","author":"M Noguchi","year":"1993","unstructured":"Noguchi, M. et al. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science 262, 1877\u20131880 (1993).","journal-title":"Science"},{"key":"31344_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0092-8674(93)90167-O","volume":"73","author":"M Noguchi","year":"1993","unstructured":"Noguchi, M. et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73, 147\u2013157 (1993).","journal-title":"Cell"},{"key":"31344_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.stemcr.2020.10.007","volume":"16","author":"J Han","year":"2021","unstructured":"Han, J. et al. beta-globin lentiviral vectors have reduced titers due to incomplete vector RNA genomes and lowered virion production. Stem Cell Rep. 16, 198\u2013211 (2021).","journal-title":"Stem Cell Rep."},{"key":"31344_CR14","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1172\/JCI61852","volume":"122","author":"A Moiani","year":"2012","unstructured":"Moiani, A. et al. Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts. J. Clin. Invest 122, 1653\u20131666 (2012).","journal-title":"J. Clin. Invest"},{"key":"31344_CR15","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1182\/blood-2012-03-420273","volume":"121","author":"RK Merling","year":"2013","unstructured":"Merling, R. K. et al. Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells. Blood 121, e98\u2013e107 (2013).","journal-title":"Blood"},{"key":"31344_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cell.2008.07.020","volume":"134","author":"A Marson","year":"2008","unstructured":"Marson, A. et al. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134, 521\u2013533 (2008).","journal-title":"Cell"},{"key":"31344_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.1154040","volume":"320","author":"SR Viswanathan","year":"2008","unstructured":"Viswanathan, S. R., Daley, G. Q. & Gregory, R. I. Selective blockade of microRNA processing by Lin28. Science 320, 97\u2013100 (2008).","journal-title":"Science"},{"key":"31344_CR18","doi-asserted-by":"publisher","first-page":"843","DOI":"10.4161\/cc.8.6.7907","volume":"8","author":"ME Peter","year":"2009","unstructured":"Peter, M. E. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 8, 843\u2013852 (2009).","journal-title":"Cell Cycle"},{"key":"31344_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.stem.2018.03.012","volume":"22","author":"M Cesana","year":"2018","unstructured":"Cesana, M. et al. A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development. Cell Stem Cell 22, 575\u2013588.e577 (2018).","journal-title":"Cell Stem Cell"},{"key":"31344_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","volume":"62","author":"D Viskochil","year":"1990","unstructured":"Viskochil, D. et al. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62, 187\u2013192 (1990).","journal-title":"Cell"},{"key":"31344_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1126\/science.2134734","volume":"249","author":"MR Wallace","year":"1990","unstructured":"Wallace, M. R. et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249, 181\u2013186 (1990).","journal-title":"Science"},{"key":"31344_CR22","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1182\/bloodadvances.2020001730","volume":"4","author":"M Bosticardo","year":"2020","unstructured":"Bosticardo, M. et al. Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia. Blood Adv. 4, 2611\u20132616 (2020).","journal-title":"Blood Adv."},{"key":"31344_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41573-019-0020-9","volume":"18","author":"M Cavazzana","year":"2019","unstructured":"Cavazzana, M., Bushman, F. D., Miccio, A., Andre-Schmutz, I. & Six, E. Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges. Nat. Rev. Drug Disco. 18, 447\u2013462 (2019).","journal-title":"Nat. Rev. Drug Disco."},{"key":"31344_CR24","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1172\/JCI35700","volume":"118","author":"S Hacein-Bey-Abina","year":"2008","unstructured":"Hacein-Bey-Abina, S. et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest 118, 3132\u20133142 (2008).","journal-title":"J. Clin. Invest"},{"key":"31344_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1126\/science.1088547","volume":"302","author":"S Hacein-Bey-Abina","year":"2003","unstructured":"Hacein-Bey-Abina, S. et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415\u2013419 (2003).","journal-title":"Science"},{"key":"31344_CR26","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1172\/JCI35798","volume":"118","author":"SJ Howe","year":"2008","unstructured":"Howe, S. J. et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J. Clin. Invest 118, 3143\u20133150 (2008).","journal-title":"J. Clin. Invest"},{"key":"31344_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1128\/JVI.01865-08","volume":"83","author":"M Bokhoven","year":"2009","unstructured":"Bokhoven, M. et al. Insertional gene activation by lentiviral and gammaretroviral vectors. J. Virol. 83, 283\u2013294 (2009).","journal-title":"J. Virol."},{"key":"31344_CR28","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.1128\/JVI.02476-09","volume":"84","author":"S Knight","year":"2010","unstructured":"Knight, S., Bokhoven, M., Collins, M. & Takeuchi, Y. Effect of the internal promoter on insertional gene activation by lentiviral vectors with an intact HIV long terminal repeat. J. Virol. 84, 4856\u20134859 (2010).","journal-title":"J. Virol."},{"key":"31344_CR29","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1172\/JCI62189","volume":"122","author":"D Cesana","year":"2012","unstructured":"Cesana, D. et al. Whole transcriptome characterization of aberrant splicing events induced by lentiviral vector integrations. J. Clin. Invest 122, 1667\u20131676 (2012).","journal-title":"J. Clin. Invest"},{"key":"31344_CR30","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1172\/JCI37630","volume":"119","author":"E Montini","year":"2009","unstructured":"Montini, E. et al. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J. Clin. Invest 119, 964\u2013975 (2009).","journal-title":"J. Clin. Invest"},{"key":"31344_CR31","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nrc2271","volume":"7","author":"A Fusco","year":"2007","unstructured":"Fusco, A. & Fedele, M. Roles of HMGA proteins in cancer. Nat. Rev. Cancer 7, 899\u2013910 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"31344_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.febslet.2004.08.013","volume":"574","author":"R Sgarra","year":"2004","unstructured":"Sgarra, R. et al. Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer. FEBS Lett. 574, 1\u20138 (2004).","journal-title":"FEBS Lett."},{"key":"31344_CR33","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/ncb2783","volume":"15","author":"MR Copley","year":"2013","unstructured":"Copley, M. R. et al. The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells. Nat. Cell Biol. 15, 916\u2013925 (2013).","journal-title":"Nat. Cell Biol."},{"key":"31344_CR34","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1182\/bloodadvances.2018023986","volume":"3","author":"P Kumar","year":"2019","unstructured":"Kumar, P. et al. HMGA2 promotes long-term engraftment and myeloerythroid differentiation of human hematopoietic stem and progenitor cells. Blood Adv. 3, 681\u2013691 (2019).","journal-title":"Blood Adv."},{"key":"31344_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cell.2008.09.017","volume":"135","author":"J Nishino","year":"2008","unstructured":"Nishino, J., Kim, I., Chada, K. & Morrison, S. J. Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf Expression. Cell 135, 227\u2013239 (2008).","journal-title":"Cell"},{"key":"31344_CR36","doi-asserted-by":"publisher","first-page":"e00924","DOI":"10.7554\/eLife.00924","volume":"2","author":"J Nishino","year":"2013","unstructured":"Nishino, J., Kim, S., Zhu, Y., Zhu, H. & Morrison, S. J. A network of heterochronic genes including Imp1 regulates temporal changes in stem cell properties. Elife 2, e00924 (2013).","journal-title":"Elife"},{"key":"31344_CR37","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1101\/gr.6286907","volume":"17","author":"GP Wang","year":"2007","unstructured":"Wang, G. P., Ciuffi, A., Leipzig, J., Berry, C. C. & Bushman, F. D. HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res. 17, 1186\u20131194 (2007).","journal-title":"Genome Res"},{"key":"31344_CR38","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1101\/gad.1554707","volume":"21","author":"AR Young","year":"2007","unstructured":"Young, A. R. & Narita, M. Oncogenic HMGA2: short or small? Genes Dev. 21, 1005\u20131009 (2007).","journal-title":"Genes Dev."},{"key":"31344_CR39","doi-asserted-by":"publisher","first-page":"5860","DOI":"10.1182\/blood-2011-02-334425","volume":"117","author":"K Ikeda","year":"2011","unstructured":"Ikeda, K., Mason, P. J. & Bessler, M. 3\u2032UTR-truncated Hmga2 cDNA causes MPN-like hematopoiesis by conferring a clonal growth advantage at the level of HSC in mice. Blood 117, 5860\u20135869 (2011).","journal-title":"Blood"},{"key":"31344_CR40","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.omtm.2021.04.013","volume":"21","author":"MA Bonner","year":"2021","unstructured":"Bonner, M. A. et al. 3\u2032UTR-truncated HMGA2 overexpression induces non-malignant in vivo expansion of hematopoietic stem cells in non-human primates. Mol. Ther. Methods Clin. Dev. 21, 693\u2013701 (2021).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"31344_CR41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cell.2008.08.041","volume":"135","author":"FC Yang","year":"2008","unstructured":"Yang, F. C. et al. Nf1-dependent tumors require a microenvironment containing Nf1+\/\u2212 and c-kit-dependent bone marrow. Cell 135, 437\u2013448 (2008).","journal-title":"Cell"},{"key":"31344_CR42","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/mt.2012.59","volume":"20","author":"D Heckl","year":"2012","unstructured":"Heckl, D. et al. Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemia. Mol. Ther. 20, 1187\u20131195 (2012).","journal-title":"Mol. Ther."},{"key":"31344_CR43","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nmeth.4237","volume":"14","author":"CS Seet","year":"2017","unstructured":"Seet, C. S. et al. Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids. Nat. Methods 14, 521\u2013530 (2017).","journal-title":"Nat. Methods"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31344-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31344-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31344-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T13:03:38Z","timestamp":1669295018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31344-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["31344"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-31344-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-858393\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]},"assertion":[{"value":"30 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3710"}}